About me
I am an engineer, product and real-world evidence leader focused on developing physiologically grounded AI systems with translational impact in diagnostics, disease phenotyping, and therapeutic evidence generation.
Short Bio
I am the founding Product and Engineering leader at Exploris Health, where I design and build clinical foundation models and AI diagnostics for cardiovascular disease. My work spans product positioning & placement, clinical development (evidence generation) and R&D of foundational models.
Previously, I served as a Director at Idorsia, where I led Real-World Evidence, HTA Statistics, and a Computational Science group supporting both development and commercialization. Before that, I was the Global Product and Machine Learning Leader at IBM, responsible for the Life Sciences portfolio within IBM’s Global AI Team. I began my career as an Equity Structurer at Deutsche Bank, developing quantitative models in high-pressure, decision-critical environments.
Research & Innovation
My research centers on representation learning for clinical and physiological data, with an emphasis on safety, grounding, and translational utility. I develop methods that:
• model noisy, biased, and incomplete real-world data,
• guide transformers toward physiologically meaningful behavior,
• improve biomarker discovery and multimodal disease modeling,
• enhance diagnostic accuracy and treatment-effect estimation, and
• apply language models to learn new disease representations (ontologies)
My work spans diagnostics and therapeutics, supporting multiple launched products and demonstrating strong translational and regulatory impact. I focus on bridging foundational research with deployable, clinically trustworthy AI systems.
Products & Translational Impact
Toujeo
Long-acting insulin that became a blockbuster drug
Daridorexant
Orexin receptor antagonist that became the most prescribed medication in its category
Accu-Check SmartGuide CGM
Named by Thomas Schinecker (Roche CEO) as a key innovation for the group
Cardio Explorer
The most reliable in-vitro diagnostic for chronic coronary syndrome; deployed in real-world clinical settings
Leadership & Awards
2012
• Universitas 21 scholarship to study at HKU
2013
• Prize for second-highest thesis mark (energy- and resource-efficient delay-tolerant network design)
2017
• IBM Outstanding Technical Achievement Award — contribution to a Nature Medicine publication
2018
• IBM Outstanding Technical Achievement Award — transformer architecture enabling physiologically meaningful glucose prediction
2022
• IBM Outstanding Technical Achievement Award — contribution to development of a medical diagnostic
